BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19352593)

  • 1. Severe respiratory symptoms to oxaliplatin infusion: a case report of delayed hypersensitivity reaction.
    Potenza S; Nasti G; Ottaiano A; Filippelli A; Rossi F; Capuano A
    Invest New Drugs; 2010 Apr; 28(2):185-6. PubMed ID: 19352593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersensitivity reactions to oxaliplatin in two asian patients.
    Ng CV
    Ann Pharmacother; 2005 Jun; 39(6):1114-8. PubMed ID: 15886290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity reactions to oxaliplatin: a case report and the success of a continuous infusional desensitization schedule.
    Lim KH; Huang MJ; Lin HC; Su YW; Chang YF; Lin J; Chang MC; Hsieh RK
    Anticancer Drugs; 2004 Jul; 15(6):605-7. PubMed ID: 15205605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serious delayed hypersensitivity reaction to oxaliplatin.
    de Vries RS; Mattijssen EJ; van Sorge AA
    Ann Oncol; 2006 Nov; 17(11):1723-4. PubMed ID: 16757568
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxaliplatin induces a delayed immune-mediated hemolytic anemia: a case report and review of the literature.
    Noronha V; Burtness B; Murren J; Duffy TP
    Clin Colorectal Cancer; 2005 Nov; 5(4):283-6. PubMed ID: 16356307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions.
    Shao YY; Hu FC; Liang JT; Chiu WT; Cheng AL; Yang CH
    J Formos Med Assoc; 2010 May; 109(5):362-8. PubMed ID: 20497869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate and delayed hypersensitivity reactions to a single dose of oxaliplatin.
    Grewal GD; Badrick TC; Gilbar PJ
    Clin Colorectal Cancer; 2015 Jun; 14(2):128-30. PubMed ID: 25659985
    [No Abstract]   [Full Text] [Related]  

  • 8. The Effects of Prolonged Infusion on Reducing Oxaliplatin Hypersensitivity Reactions.
    Zhang X; Zhao Y; Zheng Y; Dong Y
    J Investig Allergol Clin Immunol; 2017; 27(1):65-66. PubMed ID: 28211349
    [No Abstract]   [Full Text] [Related]  

  • 9. Rechallenge with cisplatin in a patient with pancreatic cancer who developed a hypersensitivity reaction to oxaliplatin. Is skin test useful in this setting?
    Elligers KT; Davies M; Sanchis D; Ferencz T; Saif MW
    JOP; 2008 Mar; 9(2):197-202. PubMed ID: 18326929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of cardiopulmonary arrest due to hypersensitivity reaction to oxaliplatin for multiple liver and lung metastases of colon cancer].
    Tamura H; Kameyama H; Toge K; Usui K; Enomoto T; Watanabe N; Hayashi T; Shimada Y; Wakai T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1844-5. PubMed ID: 25731349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin-induced acute thrombocytopenia: a case report and review of the literature.
    Suzuki K; Oda H; Sugawara Y; Masuya M; Nakase K; Fujioka M; Imai H; Katayama N
    Intern Med; 2013; 52(5):611-5. PubMed ID: 23448774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical presentation of fever as hypersensitivity reaction to oxaliplatin.
    Khurana A; Mitsis D; Kowlgi GN; Holle LM; Clement JM
    J Oncol Pharm Pract; 2016 Apr; 22(2):319-24. PubMed ID: 25361599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
    Wong JT; Ling M; Patil S; Banerji A; Long A
    J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
    Polyzos A; Tsavaris N; Gogas H; Souglakos J; Vambakas L; Vardakas N; Polyzos K; Tsigris C; Mantas D; Papachristodoulou A; Nikiteas N; Karavokyros JG; Felekouras E; Griniatsos J; Giannopoulos A; Kouraklis G
    Oncology; 2009; 76(1):36-41. PubMed ID: 19033714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity Reactions to oxaliplatin: incidence and management.
    Gowda A; Goel R; Berdzik J; Leichman CG; Javle M
    Oncology (Williston Park); 2004 Nov; 18(13):1671-5; discussion 1676, 1680, 1683-4. PubMed ID: 15648298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent episodes of involuntary masticatory spasms induced by continuous infusion of oxaliplatin.
    Santini D; Vincenzi B; La Cesa A; Casale M; Salvinelli F; Tonini G
    J Natl Cancer Inst; 2003 Oct; 95(20):1555-6. PubMed ID: 14559882
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of local reactions to oxaliplatin infusions by peripheral versus central venous administration.
    To YY; Sutcliffe KJ; Hoen HM; Swaney RA; Nicholls JD; Crocenzi TS
    J Oncol Pharm Pract; 2016 Apr; 22(2):256-60. PubMed ID: 25762052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic uremic syndrome following the infusion of oxaliplatin: case report.
    Dahabreh I; Tsoutsos G; Tseligas D; Janinis D
    BMC Clin Pharmacol; 2006 Sep; 6():5. PubMed ID: 16968538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction.
    Saif M; Roy S; Ledbetter L; Madison J; Syrigos K
    World J Gastroenterol; 2007 Oct; 13(39):5277-81. PubMed ID: 17876901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.
    Bautista MA; Stevens WT; Chen CS; Curtis BR; Aster RH; Hsueh CT
    J Hematol Oncol; 2010 Mar; 3():12. PubMed ID: 20346128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.